Gao T, Luo JL, Guo P, Hu XW, Wei XY, Hu Y. Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease. World J Clin Cases 2024; 12(2): 314-321 [PMID: 38313633 DOI: 10.12998/wjcc.v12.i2.314]
Corresponding Author of This Article
Yan Hu, Nurse, Department of Second Thoracic Surgery, Hubei Cancer Hospital, No. 116 Zhuodaoquan South Road, Hongshan District, Wuhan 430079, Hubei Province, China. yanyan663311@163.com
Research Domain of This Article
Nursing
Article-Type of This Article
Randomized Controlled Trial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jan 16, 2024; 12(2): 314-321 Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.314
Table 1 Characteristics of the participants in terms of their demographics and health
Variables
Control group (n = 38)
Intervention group (n = 41)
P value
Gender
Male/female
21/17
26/15
0.46
Age (yr)
50.07 ± 5.88
51.04 ± 6.16
0.47
Body mass index (kg/m2)
24.8 ± 2.77
25.12 ± 3.97
0.76
Education level
Primary school and below
13
15
0.88
Junior and senior high school
20
19
College degree or above
8
7
Smoking
Yes
28
31
0.84
No
10
10
Alcohol drinking
Yes
20
26
0.33
No
18
15
Table 2 Comparison of cardiac and pulmonary functions
Variables
Control group (n = 38)
Intervention group (n = 41)
P value
LVEF (%)
Before
46.21 ± 4.72
47.01 ± 6.23
0.52
After
50.05 ± 5.80
57.61 ± 7.42
< 0.001
P value
0.001
< 0.001
FVC (L)
Before
3.53 ± 0.97
3.63 ± 1.16
0.68
After
3.65 ± 1.01
3.99 ± 1.18
0.17
P value
0.59
0.16
Table 3 Comparison of exercise endurance
Variables
Control group (n = 38)
Intervention group (n = 41)
P value
6MWT (m)
Before
219.90 ± 34.67
216.53 ± 24.25
0.61
After
232.18 ± 33.12
256.98 ± 32.00
0.001
P value
0.10
< 0.001
VO2 [mL/(kg·min)]
Before
11.23 ± 3.47
11.65 ± 4.30
0.63
After
15.72 ± 4.98
20.16 ± 5.06
< 0.001
P value
< 0.001
< 0.001
Table 4 Comparison between groups of patients in terms of Seattle Angina Questionnaire and medication compliance
Variables
Control group (n = 38)
Intervention group (n = 41)
P value
SAQ-PL
Before
59.89 ± 8.68
60.11 ± 11.16
0.92
After
62.29 ± 9.73
72.46 ± 10.51
< 0.001
P value
0.26
< 0.001
SAQ-AS
Before
53.25 ± 8.03
54.09 ± 10.66
0.69
After
59.71 ± 7.68
70.13 ± 11.19
< 0.001
P value
< 0.001
< 0.001
SAQ-AF
Before
66.78 ± 6.29
65.74 ± 7.80
0.51
After
79.87 ± 4.65
84.52 ± 9.91
0.01
P value
< 0.001
< 0.001
SAQ-TS
Before
74.91 ± 7.75
76.57 ± 8.02
0.35
After
80.08 ± 9.20
87.91 ± 9.96
< 0.001
P value
0.009
< 0.001
SAQ-DP
Before
68.22 ± 7.54
68.26 ± 8.27
0.98
After
75.17 ± 6.18
82.02 ± 6.01
< 0.001
P value
< 0.001
< 0.001
Medication compliance
7.42 ± 1.96
9.46 ± 2.99
< 0.001
Citation: Gao T, Luo JL, Guo P, Hu XW, Wei XY, Hu Y. Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease. World J Clin Cases 2024; 12(2): 314-321